Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The CV safety of diabetes treatments has long been questioned by the medical community, in particular the effect of such drugs on the risk for CV mortality, MI and stroke. Now, two new trials addressed the CV safety of dipeptidyl-peptidase IV inhibitors, and the findings have created discussion among cardiologists and endocrinologists.
http://www.healio.com/cardiology/ch...-for-cv-outcome-studies-of-diabetes-therapies
http://www.healio.com/cardiology/ch...-for-cv-outcome-studies-of-diabetes-therapies